WATERLOO, Belgium, April 6, 2010 /PRNewswire/ -- Cordis Corporation announced that Christian M. Spaulding, M.D., Ph.D., FESC, FACC, has been named as Worldwide Vice President of Medical Affairs. In this role, he will be a key leader of the company’s medical team, responsible for leading the company’s global clinical strategy. Dr. Spaulding will assume the role on June 1, and will be based in Paris.
“We are very pleased that a cardiologist of Dr. Spaulding’s stature is joining Cordis,” said Campbell Rogers, M.D., Chief Scientific Officer and Global Head R&D. “He brings a wealth of experience both in the cardiac catheterization laboratory and in clinical research. His passion for teaching has made him a valued educator around the world. He and his global team will ensure our clinical strategies are aligned with patient and physician needs.”
“I’m excited to join Cordis,” said Spaulding. “As an interventional cardiologist, I’ve enjoyed working with the corporation as an investigator. I valued the company’s high quality standards for devices and ethics in clinical research. This is a fantastic opportunity to continue innovating with new devices developed by Cordis and have a positive impact on patient outcomes.”
Dr. Spaulding is Director of the Cardiac Catheterization Laboratory at Cochin Hospital and professor of medicine at Rene Descartes University, both located in Paris, France. He is a fellow of the European Society of Cardiology and the American College of Cardiology. Dr. Spaulding received his diplomas from the Rene Descartes University with a Doctorate in medical sciences in 1988, a specialization in cardiology in 1989, a Masters degree in biological sciences in 1991, and a PhD in clinical research in 1998. He received training as a visiting resident at the Montreal Heart Institute in Canada in 1988 and as senior resident in coronary angiography and angioplasty at the Clinique Pasteur, in Toulouse France in 1989. He has published over 100 papers in peer reviewed journals, and served as principal investigator in numerous international trials of novel devices and methods of treatment.
About Cordis Corporation
Cordis Corporation, a Johnson & Johnson company, is a worldwide leader in the development and manufacture of interventional vascular technology. Through the company’s innovation, research and development, Cordis partners with interventional cardiologists worldwide to treat millions of patients who suffer from vascular disease.
Media Contact: Ben Lyons, +44-(0)20-7526-3622 office
CONTACT: Media Contact: Ben Lyons, +44-(0)20-7526-3622 office
